Vuzix Corporation — FY2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021; filed March 2, 2022. Vuzix designs, manufactures and sells augmented-reality and smart-glasses products, waveguide optics and related services, primarily for enterprise, industrial and medical markets. This is an annual filing, not a standalone fourth-quarter report.
Financial performance
| Metric | FY2021 | FY2020 | Change |
|---|---|---|---|
| Revenue | $13.16 million | $11.58 million | +14% |
| Gross profit (margin) | $2.45 million (19%) | $1.93 million (17%) | +27% |
| Operating loss | $(39.98) million | $(19.13) million | Loss increased |
| Net loss | $(40.38) million | $(17.95) million | Loss increased 125% |
| Operating cash flow | $(26.98) million | $(13.96) million | Cash use increased |
| Cash and cash equivalents at year-end | $120.20 million | $36.07 million | +$84.13 million |
| Working capital | $132.99 million | $41.96 million | Increased |
- Smart-glasses sales rose 27% to $12.67 million, led by M-Series growth; M-Series revenue was $10.25 million, up 22%. Blade revenue declined 23%, which management attributed mainly to component shortages and prior-year pricing/model comparisons.
- Engineering-services revenue fell 75% to $0.38 million as projects completed and new work was deferred; the company cited COVID-related disruption to customers’ evaluation and presentation of solutions.
- Gross profit improved partly because the inventory-obsolescence charge declined to $0.52 million from $1.27 million. FY2021 still included reserves for M300XL inventory and excess Blade components.
- Operating expenses rose substantially: R&D increased 54% to $11.67 million, selling and marketing 51% to $6.12 million, and G&A 225% to $22.50 million. G&A growth was primarily associated with non-cash stock compensation, including the new Long-Term Incentive Plan (LTIP).
- Financing activities provided $115.97 million, principally from a public equity offering and warrant exercises. Shares outstanding increased from 45.65 million to 63.67 million during the year. The company reported no current or long-term debt at year-end.
Changes, outlook and notable matters
- Revenue growth did not translate into lower losses: higher operating expenses and the absence of FY2020’s $1.31 million net debt-extinguishment gain contributed to the larger FY2021 net loss.
- Management said existing cash was expected to fund working capital and capital expenditure needs for at least the next 12 months. It planned higher investment in product development and R&D in 2022; no specific revenue or earnings guidance is provided.
- The company expects to need significant business growth to become profitable and self-funding. If cash needs exceed available resources, it may seek additional equity financing, which could dilute shareholders.
- The LTIP market-capitalization option valuation was corrected in Q4 after management revised its original valuation approach. The estimated fair value of those awards increased from approximately $12.1 million to $33.6 million. The filing reports correction of affected 2021 quarterly information and a material weakness in controls related to the initial valuation.
- Management and the auditor concluded internal control over financial reporting was ineffective as of December 31, 2021; the auditor issued an adverse opinion on those controls. The financial-statement audit opinion was unqualified. Management described plans to add technical accounting and valuation resources and report remediation progress to the audit committee.
- Other principal risks include persistent losses, uncertain adoption of AR smart glasses, intense competition, reliance on third-party and sometimes limited-source component suppliers, supply-chain and manufacturing constraints, customer order cancellations, inventory obsolescence, and exposure to tariffs and international operations.
- In January 2021, the Series A preferred holder converted its shares into 4,962,600 common shares; Vuzix paid $10 million to settle accrued dividends. The company reported no material pending legal proceedings.
Important facts for investors to verify
- Whether M-Series demand and product gross margins can grow enough to offset rising R&D, selling and administrative expenses.
- Whether component availability, especially for Blade products, improves and whether inventory levels and reserves remain appropriate.
- The company’s cash-burn trajectory, planned 2022 investment and the basis for management’s stated 12-month liquidity outlook.
- How much LTIP compensation expense may be recognized as performance milestones become probable or are achieved, and the resulting dilution.
- Progress and independent testing of controls remediation after the material weakness and adverse ICFR opinion; review the corrected 2021 quarterly figures.
- Customer and supplier concentration: one customer accounted for 10% of product revenue, while two vendors represented 38% and 24% of material purchases, respectively.